Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
The Journal of Experimental Medicine
|
March 29, 2007
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
Radek Spisek, Anjli Kukreja, Lin-Chi Chen, et al.
Cancers
|
April 3, 2021
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Daniela Damasceno, Julia Almeida, Cristina Teodosio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myeloma
Heinz Ludwig, Vanessa Bolejack, John Crowley, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Blood
|
February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.
Haematologica
|
January 18, 2024
Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study
Slavisa Ninkovic, Simon J Harrison, Je-Jung Lee, et al.
Blood Cancer Journal
|
October 10, 2019
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network
Cinnie Yentia Soekojo, Kihyun Kim, Shang-Yi Huang, et al.
Annals of Hematology
|
February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
Vania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Blood Cancer Journal
|
December 3, 2021
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 10, 2018
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
Roberto José Pessoa de Magalhães Filho, Edvan Crusoe, Eloisa Riva, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
The Journal of Experimental Medicine
|
March 29, 2007
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
Radek Spisek, Anjli Kukreja, Lin-Chi Chen, et al.
Cancers
|
April 3, 2021
Monocyte Subsets and Serum Inflammatory and Bone-Associated Markers in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
Daniela Damasceno, Julia Almeida, Cristina Teodosio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 24, 2010
Survival and years of life lost in different age cohorts of patients with multiple myeloma
Heinz Ludwig, Vanessa Bolejack, John Crowley, et al.
Blood
|
February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2
Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Blood
|
February 5, 2011
Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1
S Vincent Rajkumar, Jean-Luc Harousseau, Brian Durie, et al.
Haematologica
|
January 18, 2024
Carfilzomib, thalidomide, and dexamethasone are safe and effective in relapsed and/or refractory multiple myeloma: final report of the single-arm, multicenter, phase II ALLG MM018/AMN002 study
Slavisa Ninkovic, Simon J Harrison, Je-Jung Lee, et al.
Blood Cancer Journal
|
October 10, 2019
Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma Network
Cinnie Yentia Soekojo, Kihyun Kim, Shang-Yi Huang, et al.
Annals of Hematology
|
February 8, 2019
Survival differences in multiple myeloma in Latin America and Asia: a comparison involving 3664 patients from regional registries
Vania T M Hungria, Jae Hoon Lee, Angelo Maiolino, et al.
Blood Cancer Journal
|
December 3, 2021
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Carlos Fernández de Larrea, Robert Kyle, Laura Rosiñol, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
October 10, 2018
Analysis of Availability and Access of Anti-myeloma Drugs and Impact on the Management of Multiple Myeloma in Latin American Countries
Roberto José Pessoa de Magalhães Filho, Edvan Crusoe, Eloisa Riva, et al.
Page
of 4